Author

Solomon B. Margolin

Observed names: S B Margolin, S. B. Margolin, S. Margolin, S.B Margolin, Solomon B MARGOLIN, Solomon B Margolin, Solomon Margolin

Observed institutions: University of Leicester, Leicester General Hospital, Shionogi (Japan), Tokyo Women's Medical University

OpenAlex ID: A5014547351

Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.

1995 · S N Iyer, J S Wild, et al. · PubMed · 215

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin‐diabetic rats

2001 · Goran Miric, Catherine Dallemagne, et al. · British Journal of Pharmacology · 209

PDF

Pirfenidone effectively reverses experimental liver fibrosis

2002 · Leonel Garcı́a, Ivan Hernández, et al. · Journal of Hepatology · 173

Pirfenidone improves renal function and fibrosis in the post-obstructed kidney

1998 · Toshikatsu Shimizu, Takayuki Kuroda, et al. · Kidney International · 162

Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA‐salt hypertensive rats

2002 · Stevo Mirkovic, Anne‐Marie L Seymour, et al. · British Journal of Pharmacology · 128

PDF

Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats

1995 · Hideiku Suga, Satoshi Teraoka, et al. · Experimental and Toxicologic Pathology · 110

Pirfenidone: A Novel Pharmacological Agent That Inhibits Leiomyoma Cell Proliferation and Collagen Production

1998 · Byung-Seok Lee, Solomon B. Margolin, et al. · The Journal of Clinical Endocrinology & Metabolism · 107

Lung Fibrosis is Ameliorated by Pirfenidone Fed in Diet After the Second Dose In A Three-Dose Bleomycin-Hamster Model

1998 · Swarnalatha N. Iyer, S. B. Margolin, et al. · Experimental Lung Research · 103

Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.

2001 · T D Hewitson, K J Kelynack, et al. · PubMed · 86

Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice

1997 · James P. Kehrer, Solomon B. Margolin · Toxicology Letters · 78

Effects of pirfenidone on the generation of reactive oxygen species in vitro.

1999 · S N Giri, S Leonard, et al. · PubMed · 77

Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts

1998 · M Kaneko, H Inoue, et al. · Clinical & Experimental Immunology · 76

PDF

Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats

2004 · Xiaogu Du, Edward Schelegle, et al. · Cancer Chemotherapy and Pharmacology · 62

Pirfenidone Blocks the In Vitro and In Vivo Effects of Staphylococcal Enterotoxin B

2002 · Martha L. Hale, Solomon B. Margolin, et al. · Infection and Immunity · 52

A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis

2005 · Jonathan E Walker, Shri N Giri, et al. · Multiple Sclerosis Journal · 46

Effect of pirfenidone against vanadate-induced kidney fibrosis in rats

2002 · Mohammed Ali Al-Bayati, Yan Xie, et al. · Biochemical Pharmacology · 46

Pharmacokinetics and metabolism of a novel antifibrotic drug pirfenidone, in mice following intravenous administration

2002 · Shri N. Giri, Qingjian Wang, et al. · Biopharmaceutics & Drug Disposition · 45

A phase II trial of pirfenidone (5‐methyl‐1‐phenyl‐2‐[1H]‐pyridone), a novel anti‐fibrosing agent, in myelofibrosis with myeloid metaplasia

2001 · Ruben A. Mesa, Ayalew Tefferi, et al. · British Journal of Haematology · 45

Pirfenidone Inhibits Obliterative Airway Disease in Mouse Tracheal Allografts

2005 · Hailan Zhou, Christopher W. Latham, et al. · The Journal of Heart and Lung Transplantation · 38

Pirfenidone inhibits obliterative airway disease in a murine heterotopic tracheal transplant model1

2004 · Brice W. McKane, Felix Fernandez, et al. · Transplantation · 32

Pirfenidone for chronic progressive multiple sclerosis

2001 · Jonathan E Walker, Solomon B Margolin · Multiple Sclerosis Journal · 32

Pirfenidone attenuates ischaemia–reperfusion injury in the rat small intestine

2002 · Thiruma V Arumugam, Ian A Shiels, et al. · Clinical and Experimental Pharmacology and Physiology · 27

Open-label study of pirfenidone in patients with progressive forms of multiple sclerosis

2003 · James D Bowen, Kenneth Maravilla, et al. · Multiple Sclerosis Journal · 26

Pirfenidone prevents the progression of irreversible glomerular sclerotic lesions in rats

1997 · Fujio SHIMIZU, Masafumi FUKAGAWA, et al. · Nephrology · 26

Pharmacokinetics of an antifibrotic agent, pirfenidone, in haemodialysis patients

1997 · M. Taniyama, S. Ohbayashi, et al. · European Journal of Clinical Pharmacology · 26

Works count: 39

Citation count: 2,151

H-index: 25

I10-index: 31